beta-lapachone has been researched along with 2,3,4,10-tetrahydro-7,10-dimethyl-2,4-dioxobenzo(g)pteridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Depledge, P; Hamilton, NM; Hamilton, NS; Hitchin, JR; Hopkins, GV; Jordan, AM; Maguire, LA; McGonagle, AE; Mould, DP; Ogilvie, DJ; Raoof, A; Rushbrooke, M; Small, HF; Smith, KM; Thomson, GJ; Turlais, F; Waddell, ID; Waszkowycz, B; Watson, AJ | 1 |
| Hu, Y; Jadhav, P; Tan, B; Tan, H; Wang, J | 1 |
1 review(s) available for beta-lapachone and 2,3,4,10-tetrahydro-7,10-dimethyl-2,4-dioxobenzo(g)pteridine
| Article | Year |
|---|---|
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease.
Topics: Antiviral Agents; Coronavirus Papain-Like Proteases; COVID-19 Drug Treatment; Humans; Pandemics; Protease Inhibitors; SARS-CoV-2 | 2022 |
1 other study(ies) available for beta-lapachone and 2,3,4,10-tetrahydro-7,10-dimethyl-2,4-dioxobenzo(g)pteridine
| Article | Year |
|---|---|
Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase II.
Topics: Phosphoric Diester Hydrolases; Pyrimidinones; Structure-Activity Relationship; Topoisomerase II Inhibitors; Triazines | 2013 |